| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.3 | 0.04 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |